Filing Flows › ADC Therapeutics SA (ADCT) › Recalls, complaints & regulation
ADC Therapeutics SA (ADCT): clinical trials
ADC Therapeutics SA (ADCT) beyond its filings: 2 active clinical trials.
ADC Therapeutics SA's latest quarter
ADC Therapeutics SA, Q2 2026: revenue $19.2M (+2% year over year), operating margin -132.0%, net loss $16.6M, operating cash flow −$11.8M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does ADC Therapeutics SA have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.